SUNDAY |
2:00 pm - 9:00 pm | Arrival and Check-in |
6:00 pm | Dinner |
7:30 pm - 9:30 pm | New Paradigms For Molecular Detection |
7:30 pm - 7:40 pm | Discussion Leader: Peter Greenwald, M.D., Dr.PH. National Cancer Institute |
7:40 pm - 8:10 pm | David Sidransky, M.D., Johns Hopkins University Molecular Screening and Detection |
8:10 pm - 8:40 pm | Joe Gray, Ph.D. , University of California San Francisco Genomic Events in Low Grade and Stage Breast and Ovarian Cancer as Early Detection Markers |
8:40 pm - 9:10 pm | Richard Smith, Ph.D., Pacific Northwest National Laboratory New Proteome Analysis Technologies for Cancer Research |
9:10 pm - 9:30 pm | Discussant |
| Reception to follow |
MONDAY |
7:30 am - 8:30 am | Breakfast |
8:30 am | Group Photo |
9:00 am - 12:30 pm | Molecular Profiling for Cancer Detection and Cancer Risk Identification |
9:00 am - 9:20 am | Discussion Leader: Anne-Lise Borresen-Dale, Oslo |
9:20 am - 10:00 am | Todd Golub, Ph.D., Massachusetts Institute of Technology Genomic Information and Cancer |
10:00 am - 10:30 am | Coffee Break |
10:30 am - 11:00 am | Steve Meltzer, M.D.
Analytic Approach to Genomic Data |
11:00 am - 11:30 am | Bruce Ponder, Ph.D. Cambridge University, UK
The Prospects for SNP-Based Risk Profiles for Breast Cancer |
11:30 am - 12:00 pm | Nancy Kiviat, M.D., Ph.D., University of Washington Molecular Markers for Cancer Screening: Promise and Potential Problems |
12:00 pm - 12:10 pm | Poster Presenter: Michael Barrett, Agilent Laboratories |
12:10 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 6:00 pm | Poster Session |
6:00 pm | Dinner |
7:30 pm - 9:30 pm | Cancer Cell Detection Strategies |
7:30 pm - 7:40 pm | Discussion Leader: Jeffrey Marks, Duke University |
7:40 pm - 8:10 pm | Richard Cote, M.D. University of Southern California Occult Cancer Cells |
8:10 pm - 8:40 pm | Bogdan Cerniak, M.D., University of Texas MD Anderson Genomic and Cytologic Approaches to Bladder Cancer Detection |
8:40 pm - 9:10 pm | Jose Costa, M.D., Yale School of Medicine Mutational load in early detection |
9:10 pm - 9:20 pm | Poster Presenter: Bonnie L. King, Yale University School of Medicine |
9:20 pm - 9:30 pm | Discussion |
TUESDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Promises and Challenges In Application of Proteomic Approaches for Cancer Detection |
9:00 am - 9:20 am | Discussion Leader: Emanuel Petricoin, Ph.D., FDA |
9:20 am - 10:00 am | Lance Liotta, M.D., National Cancer Institute Proteomic Pattern Diagnostics: Moving Towards the Bedside |
10:00 am - 10:30 am | Coffee Break |
10:30 am - 11:10 am | John Semmes, Ph.D., Eastern Virginia Medical School Protein Profiling and Early Detection of Cancer: Progress made and hurdles to overcome |
11:10 am - 11:40 am | Julio Celis, Ph.D., Danish Center for Human Genome Research Proteomics and Functional Genomics in Translational Breast Cancer Research |
11:40 am - 11:50 am | Poster Presenter: Bin Ye, Brigham and Women's Hospital |
11:50 am - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 6:00 pm | Poster Session #2 |
6:00 pm | Dinner |
7:30 pm - 9:30 pm | Promises and Challenges of Epigenomic in Cancer Detection |
7:30 pm - 7:40 pm | Discussion Leader: James Herman, M.D., Johns Hopkins University |
7:40 pm - 8:10 pm | Peter Laird, Ph.D., University of Southern California Epigenetics Alterations In Esophageal Cancer (tentative) |
8:10 pm - 8:40 pm | Adi Gazdar, M.D., University of Texas Southwestern Medical School Hypermethylation in Lung Carcinoma (tentative) |
8:40 pm - 9:10 pm | David Botstein, Ph.D., Stanford University
Genome-Wide Patterns of Gene Expression in Cancer |
9:10 pm - 9:20 pm | Poster Presenter: Brian Vuillemenot, Lovelace Respiratory Research Institute |
9:20 pm - 9:30 pm | Discussion |
WEDNESDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Models and Tools for Cancer Detection |
9:00 am - 9:20 am | Discussion Leader: Robert Strausberg, Ph.D., The
Institute for Genomic Research |
9:20 am - 10:00 am | Coffee Break |
10:30 am - 11:00 am | Andrew Simpson, Ph.D., Ludwig Institute Sequence-based Definition of Cancer Transcriptomes As A Route to the Identification of Therapeutic Targets |
11:00 am - 11:30 am | Greg Riggins, Ph.D., Duke University Hunting for Cancer-Specific Gene Expression with SAGE Genie |
11:30 am - 12:00 pm | Frank Diehl, Ph.D., Johns Hopkins University Non-Invasive Tests for the Detection of Colorectal Tumor Using Fecal DNA |
12:00 pm - 12:20 pm | Kornelia Polyak, M.D., Ph.D., Harvard Medical School DCIS Markers for Early Brest Cancer Diagnosis |
12:20 pm - 12:30 pm | Poster Presenter: Nam Kim, DIADEXUS |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 6:00 pm | Poster Session #3 |
6:00 pm | Dinner |
7:30 pm - 9:30 pm | Novel Approaches to Biomarker Validation |
7:30 pm - 7:40 pm | Discussion Leader: William Bigbee, Ph.D., University of Pittsburgh |
7:40 pm - 8:00 pm | Curt Harris, M.D., National Cancer Institute p53: At the Crossroads of Cancer Detection and Diagnosis |
8:00 pm - 8:20 pm | Steve Belinsky, Ph.D., Lovelace Respiratory Research Institute Gene Targets for Methylation in Lung Cancer: Utility for Predicting Risk |
8:20 pm - 8:40 pm | Claudia Henschke, M.D., Cornell University Identification and Characterization of Cancer Biomarkers in the Context of CT Screening |
8:40 pm - 9:00 pm | Barnett S. Kramer, M.D., National Institutes of Health Validation Study Designs |
9:00 pm - 9:20 pm | Nazneen Rehman, Ph.D., Institute of Cancer Research, UK Low Penetrance Breast Cancer Susceptibility Alleles: Identification, Characterization and Clinical Study |
9:20 pm - 9:30 pm | Discussion |
THURSDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Computational Tools for the Analysis of Cancer Signatures |
9:00 am - 9:20 am | Discussion Leader: John Weinstein, M.D., National Cancer Institute |
9:20 am - 10:00 am | Pablo Tamayo, Ph.D., Whitehead Institute of Genomics Gene Set Enrichment Analysis of Molecular Markers |
10:00 am - 10:30 am | Coffee Break |
10:30 am - 11:00 am | Ken Buetow, Ph.D., National Cancer Institute Interpreting Cancer Signatures Through the Lens of Biological Pathways and Process |
11:00 am - 11:30 am | Sam Hanash, M.D., University of Michigan
Computational Tools for Integrated Genomic and Proteomic Profiles |
11:30 am - 11:50 am | Yutaka Yasui, Fred Hutchinson Cancer Center
Data analytic strategies for proteomic biomarker discovery from complex high-dimensional SELDI/MALDI-TOF output |
11:50 am - 12:00 pm | Poster Presenter: Hiroyuki Aburtani, University of Tokyo |
12:00 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 6:00 pm | Poster Session #4 |
6:00 pm | Dinner |
7:30 pm - 9:30 pm | Molecular Diagnosis: From Bench to the Bedside |
7:30 pm - 7:40 pm | Discussion Leader: Gordon Mills, M.D., M.D.
Anderson Cancer Center |
7:40 pm - 8:10 pm | Ian Jacob, M.D., St. Bartholomew's & Royal London School of Medicine and Dentistry Progress and Challenges In Screening for early Detection of Ovarian Cancer |
8:10 pm - 8:40 pm | Eleftherios Diamandis, M.D., Mt. Sinai Hospital Cancer Biomarkers: From Discovery to Clinical Practice - Kallikriens as an Example |
8:40 pm - 9:00 pm | David Fishman, M.D., Northwestern School of Medicine The Tumor Microenvironment: Key to Early Detection |
9:00 pm - 9:20 pm | Mauro Ferrari, Ohio State University
Nanotechnology as A Tool Box for Early Detection |
9:20 pm - 9:30 pm | Discussion |
FRIDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am | Depart |